Cost-effectiveness and safety of the CADScorSystem in patients with symptoms suggestive of stable coronary artery disease.

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Doctor Kim Wadt Skak-Hansen

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

7 More presentations in this session

Presentation thumbnail

Effects of Beta-Blockers on Quality of Life and Well-being in Patients with Myocardial Infarction and Preserved Left Ventricular Function - a prespecified substudy from REDUCE-AMI

Associate Professor R. Hofmann (Stockholm, SE)

Presentation thumbnail

Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: prespecified substudy from REDUCE-AM

Mr P. Leissner (Uppsala, SE)

Presentation thumbnail

Coronary computed tomography angiography guided management of patients with stable chest pain: 10-year outcomes from the SCOT-HEART trial

Professor M. Williams (Edinburgh, GB)

Presentation thumbnail

Adherence to Nordic and Mediterranean dietary patterns may be associated with a lower absolute risk of incident atherosclerotic cardiovascular disease

Doctor C. Bork (Aalborg, DK)

Presentation thumbnail

Cardiorenal effects and safety of initiation of empagliflozin after acute myocardial infarction

Professor D. Bhatt (New York City, US)

Access the full session

Session thumbnail

Smaller trials, trial updates, and other studies on coronary artery disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Presentation

Real-world evaluation of an algorithmic machine-learning-guided testing approach in stable chest pain: a multinational, multicohort study

Congress Session

Evolutions in arrythmia and syncope management

Congress Presentation

EHRs and Omics for disease phenotypin

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources